Reversal after profound block in renal impairment
62-year-old woman, 95 kg, BMI 34, type 2 diabetes and CKD stage 3b (eGFR 30 mL/min/1.73 m2), scheduled for laparoscopic hysterectomy. Anesthesia includes rocuronium 0.6 mg/kg (57 mg) at induction, then two maintenance doses of 10 mg, the last 45 minutes before the end of surgery. Neuromuscular monitoring is quantitative (acceleromyography) at the adductor pollicis with train-of-four: at the end of surgery the TOF count is 1 of 4, post-tetanic count is 8, and no fade can be measured because there is only one twitch. Core temperature is 35.8 C, end-tidal sevoflurane 1.2%, and the surgical field is dry. She snores at home and has a STOP-BANG score of 5. The trachea is still intubated and she is breathing 400 mL tidal volumes at 10/min on pressure support.
1. Choose your reversal agent and dose, and justify the choice against the alternatives.
Read the worked answer
Choose sugammadex 4 mg/kg (380 mg) IV as a single bolus. The dose is set by depth of block: TOF count 1 with a post-tetanic count of 8 is a deep-to-profound block, and 2 mg/kg is only adequate at TOF count 2 or more. 4 mg/kg is the correct dose for immediate reversal of a profound block at this depth.
Why not neostigmine. Neostigmine has a ceiling effect and works only by increasing acetylcholine at the neuromuscular junction. At a TOF count of 1 it cannot reliably restore a train-of-four ratio above 0.9, and it takes 10-15 minutes to work. Giving it here would risk extubating a patient with residual block, which is the single most modifiable cause of postoperative respiratory complications. It would also require glycopyrrolate to prevent bradycardia.
Renal considerations. Sugammadex is cleared renally, and in an eGFR of 30 the rocuronium-sugammadex complex is eliminated slowly. The drug still works - efficacy is not significantly reduced in moderate renal impairment - but the duration of effect may be prolonged and the complex persists. Use the recommended dose, monitor quantitatively until a TOF ratio above 0.9 is sustained, and do not rely on a single reading. Product labelling restricts use in severe renal impairment in some jurisdictions, so document the reasoning; the alternative - leaving residual blockade - is worse.
Timing. Give the sugammadex, wait for a TOF ratio above 0.9 (typically 2-3 minutes at this dose), and only then consider extubation. Keep the patient intubated until then.
2. What criteria will you require before extubation, given her OSA and the depth of block, and what monitoring will you arrange afterwards?
Read the worked answer
Airway and recovery criteria - all must be met, not most of them:
- Quantitative TOF ratio sustained above 0.9, measured at the adductor pollicis with the same device, on at least two consecutive readings.
- Sustained head lift for 5 seconds, or a sustained bite.
- Tidal volume of at least 5-6 mL/kg with a respiratory rate that is appropriate, not a compensatory tachypnea, and an EtCO2 within the normal range.
- Awake and following commands, with a gag and swallow.
- Core temperature at least 36 C, since hypothermia prolongs blockade and impairs respiratory muscles.
- Hemodynamics stable and the surgical field dry.
Why this matters more in her. She has OSA with a STOP-BANG of 5 and a BMI of 34, so her reserve is small and residual paralysis would compound obstruction. A TOF ratio of 0.7-0.9 - which feels adequate clinically - is associated with impaired hypoxic ventilatory drive and a markedly increased risk of postoperative pulmonary complications.
Afterwards: extubate in a head-up position, keep her in a monitored area with continuous oximetry and capnography if available, avoid long-acting opioids, use multimodal analgesia, and consider CPAP if she uses it at home. Because sugammadex clearance is delayed, watch for the rare possibility of recurarization in the recovery room and continue quantitative monitoring where feasible. Discharge criteria should include stable room-air saturation while drowsy.
3. The patient then reports that a previous anesthetic was complicated by facial swelling and hypotension after a muscle relaxant, and the surgeon asks for 'the same one as last time'. How do you respond and what is the plan?
Read the worked answer
Do not give rocuronium. A history of facial swelling and hypotension after a neuromuscular blocker is a suspected perioperative anaphylaxis until proven otherwise, and the most common culprits are exactly this class. The surgeon's preference is not a reason to re-expose her.
Establish the facts and get tested. Obtain the previous anesthetic record and the drugs used. Arrange allergy testing with skin prick and intradermal testing plus specific IgE where available, performed weeks after the event by a team experienced in perioperative allergy. Do not rely on the history alone to identify the agent, but do treat the history as a contraindication in the meantime.
Plan a different technique.
- Avoid all aminosteroid relaxants (rocuronium, vecuronium, pancuronium) because of cross-reactivity, and document this on the allergy band and in the record.
- Use cisatracurium or atracurium if a blocker is needed, with quantitative monitoring; note that cisatracurium is benzylisoquinolinium and has a different structure, though cross-reactivity is not zero.
- If the procedure can be done without paralysis, do so; maintain with a volatile agent or total intravenous anesthesia.
- Have an anaphylaxis kit ready regardless, and avoid other agents with a similar history, such as chlorhexidine and antibiotics.
Important point: sugammadex encapsulates rocuronium; it is not a treatment for anaphylaxis and must not be presented as one. Anaphylaxis is treated with adrenaline, fluids, oxygen and stopping the trigger - not with reversal agents.